We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+4.66%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$968M
AUM Growth
+$854M
Cap. Flow
+$792M
Cap. Flow %
81.87%
Top 10 Hldgs %
57.56%
Holding
371
New
110
Increased
49
Reduced
126
Closed
30

Top Buys

Rank Stock Value
1
EQM
EQM Midstream Partners, LP
EQM
+$80.7M
2
ETP
Energy Transfer Partners, L.P.
ETP
+$75.4M
3
MPLX icon
MPLX
MPLX
+$75.1M
4
MPC icon
Marathon Petroleum
MPC
+$60.6M
5
WMB icon
Williams Companies
WMB
+$40.5M

Top Sells

Rank Stock Value
1
VPU
Vanguard Utilities ETF
VPU
+$1.7M
2
VDE icon
Vanguard Energy ETF
VDE
+$1.28M
3
INDA icon
iShares MSCI India ETF
INDA
+$1.24M
4
FNCL icon
Fidelity MSCI Financials Index ETF
FNCL
+$1.04M
5
INCY icon
Incyte
INCY
+$637K

Sector Composition

Rank Sector Weight
1 Energy 68.15%
2 Healthcare 6.98%
3 Utilities 1.17%
4 Financials 0.09%
5 Technology 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TCRT icon
176
Alaunos Therapeutics
TCRT
$4.71M
$355K 0.04%
739
-528
-42% -$226K
BLUE
177
DELISTED
bluebird bio
BLUE
$352K 0.04%
186
-132
-42% -$273K
CTMX icon
178
CytomX Therapeutics
CTMX
$708M
$349K 0.04%
18,850
-13,484
-42% -$307K
FOLD
179
DELISTED
Amicus Therapeutics
FOLD
$349K 0.04%
28,845
-20,610
-42% -$288K
INSM icon
180
Insmed
INSM
$22.7B
$339K 0.04%
16,751
-11,967
-42% -$270K
MDGL icon
181
Madrigal Pharmaceuticals
MDGL
$12.7B
$338K 0.03%
1,578
-1,121
-42% -$281K
PGNX
182
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$326K 0.03%
51,998
-38,179
-42% -$293K
UTSL icon
183
Direxion Daily Utilities Bull 3X ETF
UTSL
$43.8M
$324K 0.03%
12,176
-16,226
-57% -$441K
EPZM
184
DELISTED
Epizyme, Inc
EPZM
$316K 0.03%
29,855
-21,348
-42% -$244K
FAS icon
185
Direxion Daily Financial Bull 3x ETF
FAS
$2.43B
$312K 0.03%
4,431
-7,893
-64% -$564K
ACGN
186
DELISTED
Aceragen Inc
ACGN
$308K 0.03%
2,037
-1,456
-42% -$208K
LJPC
187
DELISTED
La Jolla Pharmaceutical Company
LJPC
$307K 0.03%
15,261
-10,919
-42% -$285K
SIOX
188
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$301K 0.03%
15,557
-11,306
-42% -$206K
EXC icon
189
Exelon
EXC
$48.2B
$279K 0.03%
+8,973
New +$276K
SRNE
190
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$276K 0.03%
62,691
-46,025
-42% -$255K
CLSD
191
DELISTED
Clearside Biomedical
CLSD
$270K 0.03%
2,928
-2,150
-42% -$256K
MLNT
192
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$221K 0.02%
11,172
-8,201
-42% -$207K
GERN icon
193
Geron
GERN
$949M
$214K 0.02%
121,346
-86,747
-42% -$378K
NRG icon
194
NRG Energy
NRG
$28.8B
$211K 0.02%
+5,650
New +$190K
GYRE icon
195
Gyre Therapeutics
GYRE
$683M
$193K 0.02%
2,389
-1,752
-42% -$139K
TGTX icon
196
TG Therapeutics
TGTX
$8.53B
$193K 0.02%
34,423
-24,599
-42% -$281K
EPR.PRC icon
197
EPR Properties 5.75% Series C Preferred Shares
EPR.PRC
$151M
$191K 0.02%
+6,835
New +$190K
TECL icon
198
Direxion Daily Technology Bull 3x ETF
TECL
$5.05B
$169K 0.02%
10,090
-33,900
-77% -$526K
AIV.PRA
199
DELISTED
Apart. Invst and Mgt Co
AIV.PRA
$164K 0.02%
+6,338
New +$165K
AMX icon
200
America Movil
AMX
$77.1B
$161K 0.02%
10,011
+3,703
+59% +$62.5K
6 7
8
9 10

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
ALS
Andrew L. Share $214M AUM 14.75% 1-Year Est. Return

Virtus ETF Advisers's Q3 2018 Portfolio in Review

As of Q3 2018, Virtus ETF Advisers held 371 positions worth $968M, up 755% from $113M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Virtus ETF Advisers deployed $792M of net new capital in Q3 2018, opening 110 new positions and adding to 49 existing holdings. Its largest new stake was EQM Midstream Partners, LP: 1,479,454 shares worth $78.1M.

By sector, the portfolio is most concentrated in Energy at 68% of assets, up from 0.33% a quarter earlier, followed by Healthcare and Utilities.

On the sell side, the largest reduction was Vanguard Utilities ETF, an estimated $1.7M trimmed.

  • Virtus ETF Advisers's largest Q3 2018 buy was EQM Midstream Partners, LP: 1,479,454 shares worth $78.1M.
  • Virtus ETF Advisers added most to Marathon Petroleum in Q3 2018, an estimated $60.6M increase.
  • Virtus ETF Advisers's biggest Q3 2018 reduction was Vanguard Utilities ETF, cutting an estimated $1.7M.
  • Virtus ETF Advisers fully exited iShares MSCI India ETF in Q3 2018, selling an estimated $1.24M.
  • Virtus ETF Advisers's ten largest holdings make up 58% of its $968M portfolio in Q3 2018.
  • Virtus ETF Advisers opened 110 new positions and closed 30 in Q3 2018.
  • Virtus ETF Advisers's portfolio value rose 755% quarter-over-quarter to $968M.

Based on Virtus ETF Advisers's 13F filing for Q3 2018, filed 14 Nov 2018.